跳至主要内容
临床试验/NL-OMON24756
NL-OMON24756已完成不适用

The PaPa Trial: Paracetamol as an adjunct to intrapartum Remifentanil/PCA. An RCT of multimodal pain management during labor.

ot applicable0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
ot applicable
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • Pregnant, in labour, >3 centimetres dilatation.
  • Pain request during labour, medication of choice: Remifentanil/ PCA.
  • Age 18 years and older.
  • Able to understand the written and verbal information about the PaPa Trial.

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • Refusal for participation in the PaPa Trial
  • No adequate communication possible (e.g. language barrier)
  • Use of other opioids, e.g. Pethidine of epidural analgesia <4 hours prior to start of Remifentanil as pain management.
  • Hypersensitivity for Paracetamol.
  • Liver- of kidneydiseases
  • Alcohol abuse
  • Glucose-6-phosphate dehydrogenase
  • Use of other medication that contains Paracetamol
  • Severe nutritional deficiency

研究者

发起方
ot applicable

相似试验